Novavax, Inc. and Isconova to Combine; Novavax’ Swedish Prospectus Approved

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCKVILLE, Md., 2013-07-08 16:00 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the approval in Sweden of its prospectus related to its recommended offer to acquire all outstanding shares and warrants (warrants series 2005-I and 2005-II) issued by Isconova AB (the ‘Offer’), which was first communicated on June 4, 2013.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC